MRVI Competitors & Alternatives
Compare Maravai Lifesciences Holdings Inc with similar stocks in the same industry
Biotechnology
MRVI
Main Stock$4.97
Tradestie Score
62
Market Cap
$454.29M
Revenue Growth
0.4%
Analyst Upside
+14.8%
Top Competitors
224 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$15.97
|
$2.02B | 44.1 | 53 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$13.94
|
$2.01B | - | 50 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$33.41
|
$1.97B | - | 60 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$9.10
|
$1.92B | - | 61 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$86.97
|
$1.92B | - | 53 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$72.15
|
$1.90B | 421.3 | 67 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$34.62
|
$1.84B | - | 60 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$28.93
|
$1.81B | - | 59 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$5.31
|
$1.78B | - | 57 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$19.00
|
$1.78B | - | 58 | Compare |
More MRVI Analysis
Data updated: Jun 15, 2026 | Industry: Biotechnology (SIC 2834)
224 stocks in this industry